Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s
08:01pm, Monday, 12'th Jan 2026
Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh businesses by the mid-2030s, as it accelerates the launch of additional drugs
Market Today: Banks, Big Tech, Biopharma and Energy Move on Policy and Deals
05:34pm, Monday, 12'th Jan 2026
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
Tempus Shares Jump After Strong Preliminary 2025 Results
01:35pm, Monday, 12'th Jan 2026
Tempus AI (TEM) shares rose about 10% on Monday after the company filed preliminary, unaudited results showing roughly $1.27 billion in 2025 revenue.The filing
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?
10:30am, Monday, 12'th Jan 2026
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth
05:47am, Monday, 12'th Jan 2026
Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.
3 Dividend Stocks to Hold for the Next 10 Years
02:45am, Monday, 12'th Jan 2026
Contrary to a common assumption, the tobacco industry isn't exactly imploding. There's still money to be made here.
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips
07:40am, Sunday, 11'th Jan 2026
The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite. The index's top payers dish up to 6.8%.
Can the Dogs of the Dow Really Beat the Magnificent 7 in 2026?
09:53am, Saturday, 10'th Jan 2026
Even suggesting that the Dogs of the Dow could outperform the Magnificent 7 in 2026 seems ludicrous.
January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy
09:52am, Saturday, 10'th Jan 2026
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its single share price. Analyst projections suggest the top ten Dow Dogs could delive
Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026
09:41am, Saturday, 10'th Jan 2026
If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.
Market Today: Meta taps nuclear; GM books $6B EV charge
05:35pm, Friday, 09'th Jan 2026
Stock News California billionaire tax splits tech leaders: Nvidia (NVDA) CEO Jensen Huang said he's âfineâ with a proposed one-time 5% California wealth tax
Deal Dispatch: Saks Faces A Luxury Liquidity Crisis, Soho House Gets Quiet
04:46pm, Friday, 09'th Jan 2026
Dealmaking persists as creditors, buyers, and investors wrestle with debt, delays, and mega-merger ambitions.
Merck is in talks to acquire Revolution Medicines in a deal that could value the cancer-drug biotech at around $30 billion
02:58pm, Friday, 09'th Jan 2026
Revolution is developing drugs that target a molecular driver of cancers.
Trade Tracker: Kevin Simpson buys FedEx, SLB and sells a covered call on Merck
01:25pm, Friday, 09'th Jan 2026
Kevin Simpson, founder and chief investment officer at Capital Wealth Planning , joins CNBC's "Halftime Report" to detail his latest portfolio moves.
Merck in Talks to Buy Revolution Medicines Per Financial Times Report
01:06pm, Friday, 09'th Jan 2026
Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.
